Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
---|---|---|---|---|---|---|---|---|---|
11382866 | July 12, 2022 | ||||||||
Patent 11318183 was granted and assigned to Mankind Pharma Ltd on May, 2022 by the United States Patent and Trademark Office. | 11318183 | May 3, 2022 | |||||||
Patent 10208030 was granted and assigned to Mankind Pharma Ltd on February, 2019 by the United States Patent and Trademark Office. | 10208030 | February 19, 2019 | |||||||
Patent 10954229 was granted and assigned to Mankind Pharma Ltd on March, 2021 by the United States Patent and Trademark Office. | 10954229 | March 23, 2021 | |||||||
Patent 10919915 was granted and assigned to Mankind Pharma Ltd on February, 2021 by the United States Patent and Trademark Office. | 10919915 | February 16, 2021 | |||||||
Patent 11246862 was granted and assigned to Mankind Pharma Ltd on February, 2022 by the United States Patent and Trademark Office. | 11246862 | February 15, 2022 | |||||||
Patent 10377710 was granted and assigned to Mankind Pharma Ltd on August, 2019 by the United States Patent and Trademark Office. | 10377710 | August 13, 2019 | |||||||
Patent 10239833 was granted and assigned to Mankind Pharma Ltd on March, 2019 by the United States Patent and Trademark Office. | 10239833 | March 26, 2019 | |||||||
Patent 10167271 was granted and assigned to Mankind Pharma Ltd on January, 2019 by the United States Patent and Trademark Office. | 10167271 | January 1, 2019 | |||||||
10752622 | August 25, 2020 | ||||||||
Patent 10526345 was granted and assigned to Mankind Pharma Ltd on January, 2020 by the United States Patent and Trademark Office. | 10526345 | January 7, 2020 | |||||||
11707502 | July 25, 2023 |